GeneDx Holdings (WGS) Operating Income: 2020-2025
Historic Operating Income for GeneDx Holdings (WGS) over the last 6 years, with Sep 2025 value amounting to -$3.3 million.
- GeneDx Holdings' Operating Income rose 58.21% to -$3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 117.28%. This contributed to the annual value of -$23.2 million for FY2024, which is 87.15% up from last year.
- Latest data reveals that GeneDx Holdings reported Operating Income of -$3.3 million as of Q3 2025, which was down 136.28% from $9.0 million recorded in Q2 2025.
- GeneDx Holdings' Operating Income's 5-year high stood at $9.0 million during Q2 2025, with a 5-year trough of -$324.9 million in Q4 2022.
- For the 3-year period, GeneDx Holdings' Operating Income averaged around -$18.4 million, with its median value being -$10.6 million (2024).
- As far as peak fluctuations go, GeneDx Holdings' Operating Income crashed by 257.88% in 2022, and later spiked by 184.70% in 2025.
- Over the past 5 years, GeneDx Holdings' Operating Income (Quarterly) stood at -$115.8 million in 2021, then plummeted by 180.60% to -$324.9 million in 2022, then skyrocketed by 92.11% to -$25.6 million in 2023, then soared by 134.34% to $8.8 million in 2024, then skyrocketed by 58.21% to -$3.3 million in 2025.
- Its Operating Income was -$3.3 million in Q3 2025, compared to $9.0 million in Q2 2025 and -$4.6 million in Q1 2025.